ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $23,340,000 | +39.1% | 135,593 | +1.4% | 0.01% | +60.0% |
| Q2 2021 | $16,774,000 | -1.3% | 133,679 | +6.6% | 0.01% | -16.7% |
| Q1 2021 | $16,998,000 | +30.1% | 125,368 | +22.8% | 0.01% | +20.0% |
| Q4 2020 | $13,067,000 | +17.2% | 102,131 | +3.1% | 0.01% | 0.0% |
| Q3 2020 | $11,150,000 | -35.2% | 99,081 | -45.1% | 0.01% | -37.5% |
| Q2 2020 | $17,204,000 | +18.5% | 180,565 | +11.7% | 0.01% | 0.0% |
| Q1 2020 | $14,524,000 | +125.3% | 161,723 | +33.0% | 0.01% | +300.0% |
| Q4 2019 | $6,446,000 | +56.3% | 121,584 | +16.5% | 0.00% | 0.0% |
| Q3 2019 | $4,124,000 | +138.9% | 104,335 | +148.3% | 0.00% | +100.0% |
| Q2 2019 | $1,726,000 | – | 42,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |